Altium Capital Management 13F-HR Quarterly holdings report by institutional manager

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL

OMB Number:		3235-0006
Expires:	Oct 31, 2018
Estimated average burden
hours per response:		23.8

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5			COLUMN 6	COLUMN 7	COLUMN 8
			VALUE	SHRS OR	SH/	PUT/	INVESTMENT	OTHER	VOTING AUTHORITY
NAME OF ISSUER	TITLE OF CLASS	CUSIP	(x$1000)	PRN AMT	PRN	CALL	DISCRETION	MANAGER	SOLE	SHARED	NONE
ADMA BIOLOGICS INC	COM	000899104	9,499,700	2,870,000	SH		SOLE		2,870,000	0	0
AKOYA BIOSCIENCES INC	COM	00974H104	4,090,000	500,000	SH		SOLE		500,000	0	0
ALPHATEC HLDGS INC	COM NEW	02081G201	4,212,000	270,000	SH		SOLE		270,000	0	0
AMYLYX PHARMACEUTICALS INC	COM	03237H101	5,427,900	185,000	SH		SOLE		185,000	0	0
ARCELLX INC	COMMON STOCK	03940C100	4,621,500	150,000	SH		SOLE		150,000	0	0
ASTRIA THERAPEUTICS INC	COM	04635X102	17,916,270	1,347,088	SH		SOLE		1,347,088	0	0
AULT DISRUPTIVE TECHS CORP	COM	05150A104	1,570,500	150,000	SH		SOLE		150,000	0	0
AVADEL PHARMACEUTICALS PLC	SPONSORED ADR	05337M104	4,580,000	500,000	SH		SOLE		500,000	0	0
BELLUS HEALTH INC NEW	COM NEW	07987C204	8,150,400	1,132,000	SH		SOLE		1,132,000	0	0
BIOHAVEN LTD	COM	G1110E107	3,551,600	260,000	SH		SOLE		260,000	0	0
BIOLINERX LTD	SPONSORED ADS	09071M205	2,020,916	2,279,657	SH		SOLE		2,279,657	0	0
BRIDGEBIO PHARMA INC	COM	10806X102	2,569,900	155,000	SH		SOLE		155,000	0	0
BRUUSH ORAL CARE INC	*W EXP 08/03/202	11750K120	43,269	360,579	SH		SOLE		360,579	0	0
CEA INDUSTRIES INC	*W EXP 02/11/202	86887P119	19,825	250,000	SH		SOLE		250,000	0	0
CHAVANT CAPITAL ACQUISITN CO	*W EXP 99/99/999	G2058L111	4,710	150,000	SH		SOLE		150,000	0	0
CHICKEN SOUP FOR THE SOUL EN	CL A	16842Q100	424,328	212,164	SH		SOLE		212,164	0	0
CHINOOK THERAPEUTICS INC	COM	16961L106	7,060,750	305,000	SH		SOLE		305,000	0	0
CINGULATE INC	*W EXP 12/10/202	17248W113	46,197	270,000	SH		SOLE		270,000	0	0
COLISEUM ACQUISITION CORP	CLASS A ORD SHS	G2263T123	872,100	85,000	SH		SOLE		85,000	0	0
COLISEUM ACQUISITION CORP	*W EXP 08/22/202	G2263T107	4,108	28,333	SH		SOLE		28,333	0	0
COLOMBIER ACQUISITION CORP	*W EXP 99/99/999	19533H116	3,605	16,666	SH		SOLE		16,666	0	0
COLOMBIER ACQUISITION CORP	CL A	19533H108	506,500	50,000	SH		SOLE		50,000	0	0
CRINETICS PHARMACEUTICALS IN	COM	22663K107	1,606,000	100,000	SH		SOLE		100,000	0	0
CTI BIOPHARMA CORP	COM	12648L601	3,570,000	850,000	SH		SOLE		850,000	0	0
CVRX INC	COM	126638105	1,910,600	205,000	SH		SOLE		205,000	0	0
CYMABAY THERAPEUTICS INC	COM	23257D103	5,406,400	620,000	SH		SOLE		620,000	0	0
DIGITAL HEALTH ACQUISITION C	*W EXP 11/02/202	253893119	12,750	150,000	SH		SOLE		150,000	0	0
DIRECT DIGITAL HOLDINGS INC	*W EXP 02/15/202	25461T113	135,000	180,000	SH		SOLE		180,000	0	0
DOUBLEDOWN INTERACTIVE CO LT	ADS	25862B109	485,790	60,876	SH		SOLE		60,876	0	0
DYNE THERAPEUTICS INC	COM	26818M108	1,785,600	155,000	SH		SOLE		155,000	0	0
EUCRATES BIOMEDICAL ACQU COR	*W EXP 10/23/202	G3141W122	4,820	133,333	SH		SOLE		133,333	0	0
FAT BRANDS INC	*W EXP 07/16/202	30258N121	896,650	227,000	SH		SOLE		227,000	0	0
GENEDX HOLDINGS CORP	COM CL A	81663L101	1,674,620	4,588,000	SH		SOLE		4,588,000	0	0
GLAUKOS CORP	COM	377322102	4,559,100	91,000	SH		SOLE		91,000	0	0
GSR II METEORA ACQUISITN COR	*W EXP 02/24/202	36263W121	2,000	50,000	SH		SOLE		50,000	0	0
GSR II METEORA ACQUISITN COR	CLASS A COM	36263W105	517,500	50,000	SH		SOLE		50,000	0	0
HARBOR CUSTOM DEVELOPMENT IN	*W EXP 05/09/202	41150T116	14,460	600,000	SH		SOLE		600,000	0	0
HARBOR CUSTOM DEVELOPMENT IN	*W EXP 10/07/202	41150T124	32,435	650,000	SH		SOLE		650,000	0	0
HARMONY BIOSCIENCES HLDGS IN	COM	413197104	979,500	30,000	SH		SOLE		30,000	0	0
ILLUMINA INC	COM	452327109	2,092,950	9,000	SH		SOLE		9,000	0	0
INNOVATIVE EYEWEAR INC	*W EXP 08/16/202	45791D117	44,768	122,400	SH		SOLE		122,400	0	0
INSPIRE MED SYS INC	COM	457730109	2,925,875	12,500	SH		SOLE		12,500	0	0
INVITAE CORP	COM	46185L103	552,420	409,200	SH		SOLE		409,200	0	0
IVERIC BIO INC	COM	46583P102	3,162,900	130,000	SH		SOLE		130,000	0	0
JEFFS BRANDS LTD	*W EXP 08/26/202	M61472110	106,058	980,770	SH		SOLE		980,770	0	0
KARYOPHARM THERAPEUTICS INC	COM	48576U106	1,967,488	505,781	SH		SOLE		505,781	0	0
KORU MEDICAL SYSTEMS INC	COM	759910102	2,890,708	685,002	SH		SOLE		685,002	0	0
LIGHTNING EMOTORS INC	*W EXP 05/18/202	53228T119	16,630	652,173	SH		SOLE		652,173	0	0
MARINUS PHARMACEUTICALS INC	COM NEW	56854Q200	1,578,127	228,714	SH		SOLE		228,714	0	0
MERSANA THERAPEUTICS INC	CALL	59045L906	3,082,911	750,100	SH	Call	SOLE		750,100	0	0
MIMEDX GROUP INC	COM	602496101	2,550,680	748,000	SH		SOLE		748,000	0	0
MURPHY CANYON ACQUISITION CO	*W EXP 01/25/202	626642110	9,000	100,000	SH		SOLE		100,000	0	0
MYRIAD GENETICS INC	COM	62855J104	4,181,400	180,000	SH		SOLE		180,000	0	0
NANOSTRING TECHNOLOGIES INC	COM	63009R109	2,237,321	225,992	SH		SOLE		225,992	0	0
NEOGENOMICS INC	COM NEW	64049M209	4,178,400	240,000	SH		SOLE		240,000	0	0
NEXALIN TECHNOLOGY INC	*W EXP 09/15/202	65345B110	9,975	105,000	SH		SOLE		105,000	0	0
NEXGEL INC	*W EXP 12/01/202	65344E115	34,875	225,000	SH		SOLE		225,000	0	0
NLS PHARMACEUTICS LTD	*W EXP 02/02/202	H57830111	30,000	200,000	SH		SOLE		200,000	0	0
NOVOCURE LTD	CALL	G6674U908	9,712,610	161,500	SH	Call	SOLE		161,500	0	0
ONFOLIO HOLDINGS INC	*W EXP 01/02/202	68277K124	28,090	200,000	SH		SOLE		200,000	0	0
OPY ACQUISITION CORP I	*W EXP 09/22/202	671005114	7,665	50,000	SH		SOLE		50,000	0	0
OPY ACQUISITION CORP I	COM CL A	671005106	512,750	50,000	SH		SOLE		50,000	0	0
PACIFIC BIOSCIENCES CALIF IN	COM	69404D108	2,061,240	178,000	SH		SOLE		178,000	0	0
PANBELA THERAPEUTICS INC	COM NEW	69833W206	148,280	335,324	SH		SOLE		335,324	0	0
PENUMBRA INC	COM	70975L107	4,459,040	16,000	SH		SOLE		16,000	0	0
PEPPERLIME HEALTH ACQUSTN CO	CLASS A ORD SHS	G70021103	1,018,500	100,000	SH		SOLE		100,000	0	0
PEPPERLIME HEALTH ACQUSTN CO	*W EXP 10/01/202	G70021111	34,949	367,500	SH		SOLE		367,500	0	0
POLISHED COM INC	*W EXP 06/02/202	28252C117	603,668	6,103,824	SH		SOLE		6,103,824	0	0
POLISHED COM INC	COM	28252C109	299,603	576,048	SH		SOLE		576,048	0	0
PROSOMNUS INC	*W EXP 04/20/202	50535E116	23,700	150,000	SH		SOLE		150,000	0	0
REATA PHARMACEUTICALS INC	CL A	75615P103	3,182,200	35,000	SH		SOLE		35,000	0	0
RELATIVITY ACQUISITION CORP	*W EXP 12/15/202	75944B114	0	100,000	SH		SOLE		100,000	0	0
REPLIMUNE GROUP INC	COM	76029N106	2,613,680	148,000	SH		SOLE		148,000	0	0
RESMED INC	COM	761152107	3,722,830	17,000	SH		SOLE		17,000	0	0
REVELATION BIOSCIENCES INC	COM NEW	76135L309	48,357	37,198	SH		SOLE		37,198	0	0
SELINA HOSPITALITY PLC	*W EXP 10/27/202	G8059B119	10,144	101,439	SH		SOLE		101,439	0	0
SILK RD MED INC	COM	82710M100	1,760,850	45,000	SH		SOLE		45,000	0	0
SURROZEN INC	*W EXP 08/01/203	86889P117	8,223	82,233	SH		SOLE		82,233	0	0
TC BIOPHARM HOLDINGS PLC	*W EXP 02/08/202	87807D111	1,880	18,823	SH		SOLE		18,823	0	0
TG VENTURE ACQUISITION CORP	*W EXP 08/15/202	87251T117	9,000	200,000	SH		SOLE		200,000	0	0
TG VENTURE ACQUISITION CORP	CLASS A COM	87251T109	2,070,000	200,000	SH		SOLE		200,000	0	0
THESEUS PHARMACEUTICALS INC	COM	88369M101	1,000,012	112,614	SH		SOLE		112,614	0	0
VAREX IMAGING CORP	COM	92214X106	3,001,350	165,000	SH		SOLE		165,000	0	0
VAXCYTE INC	COM	92243G108	1,611,640	43,000	SH		SOLE		43,000	0	0
VENTYX BIOSCIENCES INC	COM	92332V107	1,842,500	55,000	SH		SOLE		55,000	0	0
VERA THERAPEUTICS INC	CL A	92337R101	2,219,360	286,000	SH		SOLE		286,000	0	0
VERONA PHARMA PLC	SPONSORED ADS	925050106	502,000	25,000	SH		SOLE		25,000	0	0
WEARABLE DEVICES LTD	*W EXP 09/14/202	M97838110	193,672	1,411,600	SH		SOLE		1,411,600	0	0
WESTERN ACQSTN VENTURES CORP	*W EXP 09/01/202	95758L115	8,900	100,000	SH		SOLE		100,000	0	0
WESTERN ACQSTN VENTURES CORP	COM	95758L107	1,021,000	100,000	SH		SOLE		100,000	0	0
XTANT MED HLDGS INC	COM NEW	98420P308	3,970,069	6,227,559	SH		SOLE		6,227,559	0	0